Question 1

Has Christine Ciunci, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $197,135 in general payments to Christine Ciunci, MD across 6 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Christine Ciunci, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Christine Ciunci, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Bristol Myers Squibb	3	$90,185
Merck	1	$65,812
E.r. Squibb & Sons, L.L.C.	2	$41,139

Drug	Claims	Cost to plans & patients
TagrissoOsimertinib Mesylate	149	$2,540,310
LorbrenaLorlatinib	12	$249,145
LumakrasSotorasib	33	$241,738
VerzenioAbemaciclib	12	$188,563
TabrectaCapmatinib Hydrochloride	12	$120,897
TafinlarDabrafenib Mesylate	13	$70,285
Gefitinib	11	$68,241
EliquisApixaban	39	$25,418
Prochlorperazine Maleate	19	$477
Gabapentin	35	$424
Oxycodone Hcl	30	$412
Albuterol Sulfate HfaAlbuterol Sulfate	14	$379
Glycopyrrolate	15	$369
Hydroxyurea	11	$263
Dexamethasone	20	$246

Christine Ciunci, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other hematology & oncology in Philadelphia